Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8437583 | 0.90 | AGTR1 (0.40) | AGTR1 | |
| SCHEMBL8010421 | 0.90 | AGTR1 (0.40) | AGTR1 | |
| SCHEMBL5814612 | 0.89 | AGTR1 (0.43) | AGTR1 | |
| SCHEMBL8436392 | 0.88 | AGTR1 (0.39) | AGTR1 | |
| SCHEMBL7998092 | 0.88 | AGTR1 (0.44) | AGTR1 | |
| SCHEMBL8435723 | 0.88 | AGTR1 (0.38) | AGTR1 | |
| SCHEMBL8013220 | 0.86 | — | — | |
| SCHEMBL8887101 | 0.86 | AGTR1 (0.51) | AGTR1 | |
| SCHEMBL8013294 | 0.86 | AGTR1 (0.38) | AGTR1 | |
| SCHEMBL8829804 | 0.84 | AGTR1 (0.44) | AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0594019-B1 | 1-Biphenylmethyl-pyridone derivatives, their preparation and their use as angiotensin II antagonistes | BAYER AG (DE) | 2000-02-23 | — | — | EP | disclosed |
| US-5863930-A | ATHEROSCLEROSIS TREATMENT FORMED BY REACTION OF PYRIDONES WITH BIPHENYLMETHYL HALOGEN | BAYER AKTIENGESELLSCHAFT (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5596006-A | ANTIHYPERTENSIVE, ANTIATHEROSCLEROTIC AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-01-21 | — | — | US | disclosed |
| EP-0594019-A1 | Trisubstituted biphenyl as angiotensin II antagonistes | BAYER AG (DE) | 1994-04-27 | — | — | EP | disclosed |